Eslicarbazepine Acetate

Stability indicating hplc method for the determination of eslicarbazepine acetate and its impurities in bulk drugs and pharmaceutical dosage forms
Mudigonda Srinivas,1,2 Narasimha Rao Avupati,1 Shakil Sait,1 and K. Mukkanti
Journal of Liquid Chromatography & Related Technologies, 35:1550–1564, 2012
 
Enantioselective HPLC-UV method for determination of eslicarbazepine acetate (BIA 2-093) and its metabolites in human plasma
Gilberto Alves,1 Isabel Figueiredo,1 Margarida Castel-Branco,1 Ana Loureiro,2 Ana Fortuna,1 Amílcar Falcão1 * and Margarida Caramona
Biomedical chromatography Biomed. Chromatogr. 21: 1127–1134 (2007)
 
Stability indicating thin-layer chromatographic determination of eslicarbazepine acetate as bulk drug: Application to forced degradation study
Nikita V. Mali and Deepali A. Bansode
Der Pharmacia Lettre, 2016, 8 (11):38-47

Eslicarbazepine Acetate is chemically (S)-(-)-10-Acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide; BIA 2-093. Eslicarbazepine Acetate is supplied with detailed characterization data compliant with regulatory guideline. Eslicarbazepine Acetate can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Eslicarbazepine acetate.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.